Table 1.
Study schedule.
| Study period | |||||
|---|---|---|---|---|---|
| Enrolment | Randomization | Intervention (8 weekly sessions) | Post (8 weeks) | Follow-up (3 months) | |
| TIMEPOINT | T-1 | T0 | T1 | T2 | |
| Enrolment: | |||||
| Eligibility screen | X | ||||
| Informed consent | X | ||||
| Randomization | X | ||||
| Interventions: | |||||
| Treatment As Usual (TAU) | X | X | X | X | X |
| MCT-Silver | X | ||||
| Assessments: Baseline |
X | ||||
| Post-intevention | X | ||||
| Follow up | X | ||||